Cereno Scientific AB Sustainability Reports
Cereno Scientific AB is a clinical-stage biotechnology company developing epigenetic modulation therapies for rare cardiovascular and pulmonary diseases. Its pipeline includes HDAC inhibitor programs designed to address disease mechanisms such as vascular remodeling, fibrosis, and inflammation.
Sector: Manufacturing
Country: Sweden
Exchange: Nasdaq Stockholm
LEI: 549300VX8KTMYDS6NM84
FIGI: BBG00CSMZBD7
3 reports from 2021 to 2025
